The results indicate that by Augment has a comparable treatment outcome while producing less pain and potential morbidity than traditional autograft bone harvesting and transplantation.
Read BioMemetic’s release on its Augment Bone Graft.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
